Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Mahley (1988)
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.Science, 240 4852
P. George-Hyslop, R. Myers, J. Haines, L. Farrer, R. Tanzi, K. Abe, M. James, P. Conneally, R. Polinsky, J. Gusella (1989)
Familial Alzheimer's disease: Progress and problemsNeurobiology of Aging, 10
G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E. Stadlan (1984)
Clinical diagnosis of Alzheimer's diseaseNeurology, 34
EH Corder (1993)
Apolipoprotein E gene dose and the risk of Alzheimer disease in late onset familiesScience, 261
RC Mohs (1987)
Alzheimer's diseaseArch. gen. Psychiatry, 44
J. Breitner, Marshal Folstein (1984)
Familial Alzheimer Dementia: a prevalent disorder with specific clinical featuresPsychological Medicine, 14
J. Eldor (1993)
Immediate intracardiac adrenaline injection in asystoleThe Lancet, 342
R. Mayeux, Y. Stern, R. Ottman, T. Tatemichi, M. Tang, G. Maestre, C. Ngai, B. Tycko, H. Ginsberg (1993)
The apolipoprotein ε4 allele in patients with Alzheimer's diseaseAnnals of Neurology, 34
John Breitner, J. Silverman, R. Mohs, K. Davis (1988)
Familial aggregation in Alzheimer's diseaseNeurology, 38
FJ Huff, J Auerbach, A Chakravarti, F Boller (1988)
Risk of dementia in relatives with Alzheimer's diseaseNeurology, 38
G. Rebeck, Joell Reiter, D. Strickland, B. Hyman (1993)
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactionsNeuron, 11
M. Pericak-Vance, L. Yamaoka, C. Haynes, M. Speer, J. Haines, P. Gaskell, W. Hung, C. Clark, A. Heyman, J. Trofatter, J. Eisenmenger, J. Gilbert, J. Lee, M. Alberts, Deborah Dawson, R. Bartlett, N. Earl, Teepu Siddique, J. Vance, P. Conneall, A. Roses (1988)
Genetic linkage studies in Alzheimer's disease familiesExperimental Neurology, 102
J. Dausset, H. Cann, D. Cohen, M. Lathrop, J. Lalouel, J. Lalouel, Raymond White, R. White (1990)
Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome.Genomics, 6 3
K. Kishi, T. Yasuda, Y. Ikehara (1988)
Alpha-2-HS-glycoprotein polymorphism detected in human urine by isoelectric focusing and immunoblotting.Human heredity, 38 4
M. Folstein, S. Bassett, J. Anthony, A. Romanoski, G. Nestadt (1991)
Dementia: case ascertainment in a community survey.Journal of gerontology, 46 4
F. Huff, J. Auerbach, A. Chakravarti, F. Boiler (1988)
Risk of dementia in relatives of patients with Alzheimer's diseaseNeurology, 38
M. Breteler, J. Claus, C. Duijn, L. Launer, A. Hofman (1992)
Epidemiology of Alzheimer's disease.Epidemiologic reviews, 14
S. Appel (1981)
A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer diseaseAnnals of Neurology, 10
G McKhann (1984)
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's DiseaseNeurology, 34
Z. Khachaturian (1985)
Diagnosis of Alzheimer's disease.Archives of neurology, 42 11
KJ Rothman (1986)
Modern Epidemiology
S. Noguchi, K. Murakami, N. Yamada, H. Payami, J. Kaye, L. Heston, T. Bird, G. Schellenberg (1993)
Apolipoprotein E genotype and Alzheimer's diseaseThe Lancet, 342
D. Borgaonkar, L. Schmidt, S. Martin, MichaelD. Kanzer, L. Edelsohn, J. Growdon, L. Farrer (1993)
Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19The Lancet, 342
A. Saunders, W. Strittmatter, D. Schmechel, P. George-Hyslop, M. Pericak-Vance, S. Joo, B. Rosi, J. Gusella, D. Crapper-MacLachlan, M. Alberts (1993)
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.Neurology, 43 8
A. Saunders, A. Roses, M. Pericak-Vance, K. Dole, W. Strittmatter, D. Schmechel, M. Szymanski, N. McCown, M.G Manwaring, K. Schmader, J. Breitner, D. Goldgaber, M. Benson, L. Goldfarb, W.T Brown (1993)
Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseasesThe Lancet, 342
G. Schellenberg, M. Boehnke, E. Wijsman, D. Moore, G. Martin, T. Bird (1992)
Genetic association and linkage analysis of the apolipoprotein CII locus and familial Alzheimer's diseaseAnnals of Neurology, 31
G. Schellenberg, T. Bird, E. Wijsman, H. Orr, L. Anderson, E. Nemens, J. White, Lori Bonnycastle, J. Weber, M. Alonso, H. Potter, L. Heston, G. Martin (1992)
Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.Science, 258 5082
W. Strittmatter, A. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G. Salvesen, A. Roses (1993)
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 90
W. Strittmatter, A. Roses (1995)
Apolipoprotein E and Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 92 11
LA Farrer (1990)
Transmissionandage-at-onset patterns in familial Alzheimer's disease: evidence for heterogeneityNeurology, 40
E. Corder, A. Saunders, W. Strittmatter, D. Schmechel, P. Gaskell, G. Small, A. Roses, J. Haines, M. Pericak-Vance (1993)
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.Science, 261 5123
C. Broeckhoven, H. Backhovens, M. Cruts, G. Winter, M. Bruyland, P. Cras, Jean-Jacques Martin (1992)
Mapping of a gene predisposing to early–onset Alzheimer's disease to chromosome 14q24.3Nature Genetics, 2
M. Liddell, Julie Williams, A. Bayer, F. Kaiser, M. Owen (1994)
Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease.Journal of Medical Genetics, 31
G. Utermann, U. Langenbeck, U. Beisiegel, W. Weber (1980)
Genetics of the apolipoprotein E system in man.American journal of human genetics, 32 3
P. George-Hyslop, J. Haines, E. Rogaev, E. Rogaev, M. Mortilla, M. Mortilla, G. Vaula, G. Vaula, M. Pericak-Vance, J. Foncin, M. Montesi, A. Bruni, S. Sorbi, I. Rainero, L. Pinessi, D. Pollen, R. Polinsky, L. Nee, J. Kennedy, F. Macciardi, E. Rogaeva, Yan Liang, N. Alexandrova, W. Lukiw, K. Schlumpf, R. Tanzi, T. Tsuda, L. Farrer, J. Cantú, R. Duara, L. Amaducci, L. Bergamini, J. Gusella, A. Roses, D. McLachlan (1992)
Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14Nature Genetics, 2
Lindsay Farrer, R. Myers, L. Cupples, P. George-hyslop, T. Bird, Martin Rossor, Michael Mullan, R. Polinsky, L. Nee, L. Heston, C. Broeckhoven, Jean-Jaques Martin, D. Crapper-McLachlan, J. Growdon (1990)
Transmission and age‐at‐onset patterns in familial Alzheimer's diseaseNeurology, 40
O Myklebost, S Rogne (1988)
A physical map of the apolipoprotein gene cluster on chromosome 19Hum. Genet., 78
A. Goate, M. Chartier-Harlin, M. Mullan, Jeremy Brown, F. Crawford, L. Fidani, L. Giuffra, A. Haynes, N. Irving, L. James, R. Mant, P. Newton, K. Rooke, P. Roques, C. Talbot, M. Pericak-Vance, A. Roses, R. Williamson, M. Rossor, M. Owen, J. Hardy (1991)
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 349
DS Borgaonkar (1993)
Linkage of late-onset Alzheimer disease with apolipoprotein E type ε4 on chromosome 19 confirmed by family studiesLancet, 342
W. Strittmatter, K. Weisgraber, David Huang, L. Dong, G. Salvesen, M. Pericak-Vance, D. Schmechel, A. Saunders, D. Goldgaber, A. Roses (1993)
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 90 17
J. Poirier, P. Bertrand, S. Kogan, S. Gauthier, J. Davignon, D. Bouthillier (1993)
Apolipoprotein E polymorphism and Alzheimer's diseaseThe Lancet, 342
J Cornoni-Huntley, DG Blazer, C Service, ME Farmer (1990)
Established population for epidemiologic studies of the elderly. Volume II
R. Mohs, J. Breitner, J. Silverman, K. Davis (1987)
Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age.Archives of general psychiatry, 44 5
W. Strittmatter, K. Weisgraber, M. Goedert, A. Saunders, David Huang, E. Corder, Liming Dong, R. Jakes, M. Alberts, J. Gilbert, Seol-Heui Han, C. Hulette, G. Einstein, D. Schmechel, M. Pericak-Vance, A. Roses (1994)
Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E GenotypeExperimental Neurology, 125
D. Schmechel, A. Saunders, W. Strittmatter, B. Crain, C. Hulette, S. Joo, M. Pericak-Vance, D. Goldgaber, A. Roses (1993)
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 90 20
P. George-hyslop, R. Tanzi, R. Polinsky, J. Haines, L. Nee, P. Watkins, R. Myers, R. Myers, R. Feldman, D. Pollen, D. Drachman (1987)
The genetic defect causing familial Alzheimer's disease maps on chromosome 21.Science, 235 4791
M. Pericak-Vance, J. Bebout, P. Gaskell, L. Yamaoka, W. Hung, M. Alberts, A. Walker, R. Bartlett, C. Haynes, K. Welsh, N. Earl, A. Heyman, C. Clark, A. Roses (1991)
Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.American journal of human genetics, 48 6
JCS Breitner, JM Silverman, RC Mohs, KL Davis (1988)
Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, andamongmaleand female relatives in successive generationsNeurology, 38
Gene dosage of the apolipoprotein E (APOE) ε4 allele is a major risk factor for familial Alzheimer disease (AD) of late onset (after age 60). Here we studied a large series of 115 AD case subjects and 243 controls as well as 150 affected and 197 unaffected members of 66 AD families. Our data demonstrate a protective effect of the ε2 allele, in addition to the dose effect of the ε4 allele in sporadic AD. Although a substantial proportion (65%) of AD is attributable to the presence of ε4 alleles, risk of AD is lowest in subjects with the ε2/ε3 genotype, with an additional 23% of AD attributable to the absence of an ε2 allele. The opposite actions of the ε2 and ε4 alleles further support the direct involvement of APOE in the pathogenesis of AD.
Nature Genetics – Springer Journals
Published: Jun 1, 1994
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.